ISRCTN10890482
Completed
Not Applicable
Assessment of the capability of a novel bioactive polyphenol solution on the duration of diarrhoea in adults: a randomised placebo-controlled study
iveLeaf Inc0 sites150 target enrollmentJanuary 21, 2015
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- iveLeaf Inc
- Enrollment
- 150
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Age 18–80 years
- •2\. Provided informed consent
- •3\. Acute diarrhoea (for 48 hours or less)
Exclusion Criteria
- •1\. History of uncontrolled emesis
- •2\. Signs of coexisting acute sytemic illness (e.g., sepsis or pneumonia)
- •3\. Underlying chronic disease (e.g., heart disease or diabetes)
- •4\. Food allergies or other chronic gastrointestinal diseases
- •5\. Use of probiotic agents in previous 3 weeks
- •6\. Use of antibiotics or anti\-diarrhoeal medication in previous 2 weeks
- •7\. Severely malnourished
- •8\. Showed signs of internal bleeding or drug abuse
- •9\. Any condition the physician believed would put the patient at risk if given only standard treatment for diarrhoea
- •10\. Unwilling or unable to provide informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
In vitro evaluation of an innovative biocompatible Adhesive for complete retrieval of residual fragments after lithotripsyurinary calculusN20-N23UrolithiasisDRKS00010243niversitätsklinikum FreiburgDepartment ChirurgieKlilnik für Urologie15
Recruiting
Not Applicable
Prospective study of the exploration of bioactive lipid biomarker involved in ocular diseasesJPRN-UMIN000027137The University of Tokyo500
Active, not recruiting
Phase 1
Evaluation of efficacy and bioavailability of ibuprofen lysinatePain on an inflammatory basis (otitis and otomastoiditis, adenite, cellulite, arthritis) and post-operative painMedDRA version: 21.0Level: PTClassification code 10050533Term: Pain assessmentSystem Organ Class: 10022891 - InvestigationsMedDRA version: 20.1Level: LLTClassification code 10063374Term: Pain scaleSystem Organ Class: 10022891 - InvestigationsTherapeutic area: Diseases [C] - Symptoms and general pathology [C23]EUCTR2019-000647-27-ITDicofarm S.p.A.84
Completed
Phase 1
Study to assess the distribution in the blood of healthy volunteers of a new formulation of losartan compared with the marketed formulation Cozaar® administered under fasting conditionsBioavailability of a new formulation of losartanNot ApplicableISRCTN16928142DPL Pharma S.p.A.16
Completed
Not Applicable
Bioactive materials - a boon in DentistryHealth Condition 1: null- 1. Presence of at least two NCCLâ??s with equal depth (1-2 mm) 2. Patients of age ranging from 20 to 60 years3. Vital teeth5. Presence of occlusion and proximal contact with adjacent teethHealth Condition 2: Z006- Encounter for examination for normal comparison and control in clinical research programCTRI/2017/12/010787Dr Mona Yadav75